Rifampicin (a.k.a. Rifampin) iis a macrocyclic antibiotic with strong activity against gram-positive bacteria and gram-negative cocci, mycobacteria, commonly used in combination with other agents as therapy of tuberculosis, leprosy, and legionella. Rifampicin is produced by the microorganism Streptomyces mediterranei.
Intratec offers professional, easy-to-understand reports examining Rifampicin production. Each study describes an industrial plant, including main process units and site infrastructure, and presents an independent analysis of capital and operating costs. All reports are based on the most recent economic data available (Q1 2021).
You can find below reports focused on Rifampicin production processes currently offered by Intratec. If none of the off-the-shelf reports listed below fits your needs, you can request a bespoke report tailored to your needs, for as low as $2,900 USD!